arrow
N

Nicolas Venteclef

université parís cité
H指数:41
被引数:6,306

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immunity
IF26.3
2026-08-200
PRE
An islet-resident macrophage antioxidant program preserves β cell physiology

岛内居民巨噬细胞的抗氧化程序维持β细胞生理学

2025-11-140
PRE
Septal LYVE1+ macrophages control adipocyte stem cell adipogenic potential

室间隔LYVE1+巨噬细胞调控脂肪干细胞成脂分化潜能

Science
IF45.8
2025-08-280
PRE
Regulation of immune cell metabolism by therapeutic normal IgG intravenous immunoglobulin

治疗性正常IgG静脉免疫球蛋白对免疫细胞代谢的调控

2025-05-160
OAAI
Effectiveness of Six International Guidelines Using Fibrosis-4 and FibroScan for Risk Stratification of Metabolic Dysfunction-associated Steatotic Liver Disease in Type 2 Diabetes

使用Fibrosis-4和FibroScan对2型糖尿病患者代谢功能障碍相关脂肪性肝病的风险分层评估六种国际指南的有效性

2025-05-080
PRE
Impaired unsaturated fatty acid elongation alters mitochondrial function and accelerates metabolic dysfunction-associated steatohepatitis progression
2025-01-010
OA
ABCG1 orchestrates adipose tissue macrophage plasticity and insulin resistance in obesity by rewiring saturated fatty acid pools
2024-12-110
PRE
NLRP3 Inflammasome Inhibition With Dapansutrile in Type 2 Diabetes and Elevated Systemic Inflammation: Rationale and Design of the DAPANDIA study

Dapansutrile抑制NLRP3炎症小体在2型糖尿病及系统性炎症升高中的应用:DAPANDIA研究的依据与设计

2024-11-120
PRE
Fully automated epicardial adipose tissue volume quantification with deep learning and relationship with CAC score and micro/macrovascular complications in people living with type 2 diabetes: the multicenter EPIDIAB study
2024-09-031
OAAI
Blood Monocyte Phenotype Is A Marker of Cardiovascular Risk in Type 2 Diabetes
2024-01-194
OA